ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT
Clinical trials for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT explained in plain language.
Never miss a new study
Get alerted when new ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT trials appear
Sign up with your email to follow new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Fighting viruses with donor cells: new hope for transplant patients
Disease control Recruiting nowThis early-phase study is testing whether specially prepared immune cells from a donor can safely help fight two specific viruses (CMV or adenovirus) in people who have had a stem cell or organ transplant. The treatment is for patients whose infections aren't responding well to s…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT
Phase: EARLY_PHASE1 • Sponsor: Sumithira Vasu • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New transplant technique aims to stop Body's attack on itself in kids with cancer
Disease control Recruiting nowThis study is testing whether removing a specific type of immune cell (called naive T cells) from a donor's stem cells before transplant can prevent chronic graft-versus-host disease in children and young adults with blood cancers. Chronic graft-versus-host disease is a serious c…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Getting stronger before the fight: new study tests Pre-Surgery prep for blood cancer
Disease control Recruiting nowThis study is testing if a personalized exercise and nutrition program before a stem cell transplant helps patients recover better. It will compare patients who do this 'prehabilitation' to those who receive standard care alone. The main goal is to see if the program improves pat…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Disease control
Last updated Mar 16, 2026 15:27 UTC